AI-generated summary
The authors review evidence on curcumin and photobiomodulation for drug-induced gingival overgrowth, separating animal and cell studies from direct matrix outcomes. They report that curcumin reduced some enlargement-related outcomes in rats receiving phenytoin, and that one photobiomodulation study on fibroblasts showed mixed results, without clear collagen I improvement. The authors conclude that no clinical non-photodynamic combination has yet been validated.
- Who or what was studied
- Drug-associated gingival models, including rats exposed to phenytoin and gingival fibroblasts from one calcium-channel-blocker-associated lesion
- Limits stated in the abstract
- The review relies on a narrow evidence base, including a single fibroblast source and animal and in vitro data, with no validated clinical combination.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photodynamic therapy, Inflammation, Replication, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.